Liver cirrhosis mortality in 187 countries between 1980 and 2010: A systematic analysis

BMC Medicine

Volumn 12, Issue 1, 2014, Pages

  Mokdad, Ali A ^a,b   Lopez, Alan D ^c   Shahraz, Saied ^d   Lozano, Rafael ^a   Mokdad, Ali H ^a   Stanaway, Jeff ^a   Murray, Christopher J L ^a   Naghavi, Mohsen ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d BRANDEIS UNIVERSITY   (United States)

Author keywords

Alcohol; Global; Hepatitis; Liver cirrhosis; Mortality

Indexed keywords

AFRICA SOUTH OF THE SAHARA; AGE; ALCOHOL CONSUMPTION; ALCOHOL LIVER CIRRHOSIS; ARGENTINA; ARTICLE; AUTOPSY; BULGARIA; CAMBODIA; CEREBROVASCULAR DISEASE; CHILE; CHINA; COLORECTAL CANCER; COSTA RICA; COTE D'IVOIRE; EGYPT; FINLAND; FRANCE; GABON; GERMANY; GUATEMALA; HEART MUSCLE ISCHEMIA; HEPATITIS B; HEPATITIS C; HONDURAS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUNGARY; ICELAND; INDIA; INDONESIA; IRELAND; ITALY; JAPAN; KAZAKHSTAN; KYRGYZSTAN; LAOS; LIVER CIRRHOSIS; LUNG CANCER; MAJOR CLINICAL STUDY; MALAWI; MALAYSIA; MEXICO; MOLDOVA; MONGOLIA; MORTALITY; MYANMAR; PAKISTAN; PARAGUAY; PHILIPPINES; PREDICTIVE VALIDITY; PREVALENCE; ROMANIA; RUSSIAN FEDERATION; SCHISTOSOMIASIS; SEX; SINGAPORE; SOUTH KOREA; SPAIN; SRI LANKA; TAJIKISTAN; THAILAND; TURKMENISTAN; UGANDA; UKRAINE; UNITED KINGDOM; UZBEKISTAN; VIET NAM; VIRUS TRANSMISSION; WESTERN EUROPE; EPIDEMIOLOGY; EUROPE; FEMALE; GREAT BRITAIN; MALE; MIDDLE AGED; RISK FACTOR; VERY ELDERLY; YOUNG ADULT;

AGED, 80 AND OVER; CHINA; EUROPE; FEMALE; FRANCE; GREAT BRITAIN; HUMANS; ITALY; LIVER CIRRHOSIS; MALE; MEXICO; MIDDLE AGED; PREVALENCE; RISK FACTORS; YOUNG ADULT;

EID: 84908123659     PISSN: None     EISSN: 17417015     Source Type: Journal    
DOI: 10.1186/s12916-014-0145-y     Document Type: Article

References (95)

1. Murray CJ, Vos T, Lozano R, Naghavi M, Flaxman AD, Michaud C, Ezzati M, Shibuya K, Salomon JA, Abdalla S, Aboyans V, Abraham J, Ackerman I, Aggarwal R, Ahn SY, Ali MK, Alvarado M, Anderson HR, Anderson LM, Andrews KG, Atkinson C, Baddour LM, Bahalim AN, Barker-Collo S, Barrero LH, Bartels DH, Basáñez MG, Baxter A, Bell ML, Benjamin EJ, et al. Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012, 380:2197-2223. 10.1016/S0140-6736(12)61689-4, 23245608.
2. Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, Abraham J, Adair T, Aggarwal R, Ahn SY, Alvarado M, Anderson HR, Anderson LM, Andrews KG, Atkinson C, Baddour LM, Barker-Collo S, Bartels DH, Bell ML, Benjamin EJ, Bennett D, Bhalla K, Bikbov B, Bin Abdulhak A, Birbeck G, Blyth F, Bolliger I, Boufous S, Bucello C, Burch M, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012, 380:2095-2128. 10.1016/S0140-6736(12)61728-0, 23245604.
3. Bosetti C, Levi F, Lucchini F, Zatonski WA, Negri E, La Vecchia C. Worldwide mortality from cirrhosis: an update to 2002. J Hepatol 2007, 46:827-839. 10.1016/j.jhep.2007.01.025, 17336419.
4. Corrao G, Ferrari P, Zambon A, Torchio P, Aricò S, Decarli A. Trends of liver cirrhosis mortality in Europe, 1970-1989: age-period-cohort analysis and changing alcohol consumption. Int J Epidemiol 1997, 26:100-109. 10.1093/ije/26.1.100, 9126509.
5. Zatoński WA, Sulkowska U, Mańczuk M, Rehm J, Boffetta P, Lowenfels AB, La Vecchia C. Liver cirrhosis mortality in Europe, with special attention to Central and Eastern Europe. Eur Addict Res 2010, 16:193-201. 10.1159/000317248, 20606444.
6. La Vecchia C, Levi F, Lucchini F, Franceschi S, Negri E. Worldwide patterns and trends in mortality from liver cirrhosis, 1955 to 1990. Ann Epidemiol 1994, 4:480-486. 10.1016/1047-2797(94)90009-4, 7804504.
7. Rani M, Yang B, Nesbit R. Hepatitis B control by 2012 in the WHO Western Pacific Region: rationale and implications. Bull World Health Organ 2009, 87:707-713. 10.2471/BLT.08.059220, 19784451.
8. Recommendations from the Special Advisory Group of Experts. Part I. Wkly Epidemiol Rec 1996, 71:261-266.
9. Hatzakis A, Wait S, Bruix J, Buti M, Carballo M, Cavaleri M, Colombo M, Delarocque-Astagneau E, Dusheiko G, Esmat G, Esteban R, Goldberg D, Gore C, Lok AS, Manns M, Marcellin P, Papatheodoridis G, Peterle A, Prati D, Piorkowsky N, Rizzetto M, Roudot-Thoraval F, Soriano V, Thomas HC, Thursz M, Valla D, van Damme P, Veldhuijzen IK, Wedemeyer H, Wiessing L, et al. The state of hepatitis B and C in Europe: report from the hepatitis B and C summit conference*. J Viral Hepat 2011, 18:1-16. 10.1111/j.1365-2893.2011.01499.x, 21824223.
10. Chick J. The WHO global strategy to reduce the harmful use of alcohol. Alcohol Alcohol 2011, 46:223. 10.1093/alcalc/agr035, 21508193.
11. Murray CJL, Lopez AD. The Global Burden of Disease, GBD 1990 Study 1996, Harvard University Press, Cambridge, MA.
12. Wang H, Dwyer-Lindgren L, Lofgren KT, Rajaratnam JK, Marcus JR, Levin-Rector A, Levitz CE, Lopez AD, Murray CJL. Age-specific and sex-specific mortality in 187 countries, 1970-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012, 380:2071-2094. 10.1016/S0140-6736(12)61719-X, 23245603.
13. Naghavi M, Makela S, Foreman K, O'Brien J, Pourmalek F, Lozano R. Algorithms for enhancing public health utility of national causes-of-death data. Popul Health Metr 2010, 8:9. 10.1186/1478-7954-8-9, 20459720.
14. Murray CJ, Lopez AD, Barofsky JT, Bryson-Cahn C, Lozano R. Estimating population cause-specific mortality fractions from in-hospital mortality: validation of a new method. PLoS Med 2007, 4:e326. 10.1371/journal.pmed.0040326, 18031195.
15. Foreman KJ, Lozano R, Lopez AD, Murray CJ. Modeling causes of death: an integrated approach using CODEm. Popul Health Metr 2012, 10:1. 10.1186/1478-7954-10-1, 22226226.
16. Murray CJ, Rosenfeld LC, Lim SS, Andrews KG, Foreman KJ, Haring D, Fullman N, Naghavi M, Lozano R, Lopez AD. Global malaria mortality between 1980 and 2010: a systematic analysis. Lancet 2012, 379:413-431. 10.1016/S0140-6736(12)60034-8, 22305225.
17. Hogan MC, Foreman KJ, Naghavi M, Ahn SY, Wang M, Makela SM, Lopez AD, Lozano R, Murray CJL. Maternal mortality for 181 countries, 1980-2008: a systematic analysis of progress towards Millennium Development Goal 5. Lancet 2010, 375:1609-1623. 10.1016/S0140-6736(10)60518-1, 20382417.
18. Forouzanfar MH, Foreman KJ, Delossantos AM, Lozano R, Lopez AD, Murray CJ, Naghavi M. Breast and cervical cancer in 187 countries between 1980 and 2010: a systematic analysis. Lancet 2011, 378:1461-1484. 10.1016/S0140-6736(11)61351-2, 21924486.
19. Centers for Disease Control and Prevention: National Vital Statistics System Instruction Manuals. 2014, []., http://www.cdc.gov/nchs/nvss/instruction_manuals.htm
20. Alonso FT, Garmendia ML, De AM, Searle J. Mortality trend from liver cirrhosis in Chile from 1990 to 2007. Rev Med Chil 2010, 138:1253-1258. 10.4067/S0034-98872010001100007, 21279271.
21. Roberts SE, Goldacre MJ, Yeates D. Trends in mortality after hospital admission for liver cirrhosis in an English population from 1968 to 1999. Gut 2005, 54:1615-1621. 10.1136/gut.2004.058636, 15980061.
22. Ye Y, Kerr WC. Alcohol and liver cirrhosis mortality in the United States: comparison of methods for the analyses of time-series panel data models. Alcohol Clin Exp Res 2011, 35:108-115. 10.1111/j.1530-0277.2010.01327.x, 21039632.
23. Leon DA, McCambridge J. Liver cirrhosis mortality rates in Britain from 1950 to 2002: an analysis of routine data. Lancet 2006, 367:52-56. 10.1016/S0140-6736(06)67924-5, 16399153.
24. Soleman N, Chandramohan D, Shibuya K. Verbal autopsy: current practices and challenges. Bull World Health Organ 2006, 84:239-245. 10.2471/BLT.05.027003, 16583084.
25. Food and Agriculture Organization of the United Nations: National Food Balance Sheets. , []., http://faostat.fao.org/site/354/default.aspx
26. Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M, Shibuya K, Salomon JA, Abdalla S, Aboyans V, Abraham J, Ackerman I, Aggarwal R, Ahn SY, Ali MK, Alvarado M, Anderson HR, Anderson LM, Andrews KG, Atkinson C, Baddour LM, Bahalim AN, Barker-Collo S, Barrero LH, Bartels DH, Basáñez MG, Baxter A, Bell ML, Benjamin EJ, Bennett D, et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012, 380:2163-2196. 10.1016/S0140-6736(12)61729-2, 23245607.
27. Van der Werf MJ, de Vlas SJ, Brooker S, Looman CW, Nagelkerke NJ, Habbema JD, Engels D. Quantification of clinical morbidity associated with schistosome infection in sub-Saharan Africa. Acta Trop 2003, 86:125-139. 10.1016/S0001-706X(03)00029-9, 12745133.
28. Gryseels B, Polman K, Clerinx J, Kestens L. Human schistosomiasis. Lancet 2006, 368:1106-1118. 10.1016/S0140-6736(06)69440-3, 16997665.
29. Doumenge JP, Mott KE. Global distribution of schistosomiasis: CEGET/WHO atlas. World Health Stat Q 1984, 37:186-199. 6541400.
30. Hassan MM, Hwang LY, Hatten CJ, Swaim M, Li D, Abbruzzese JL, Beasley P, Patt YZ. Risk factors for hepatocellular carcinoma: synergism of alcohol with viral hepatitis and diabetes mellitus. Hepatology 2002, 36:1206-1213. 10.1053/jhep.2002.36780, 12395331.
31. Rehm J, Taylor B, Mohapatra S, Irving H, Baliunas D, Patra J, Roerecke M. Alcohol as a risk factor for liver cirrhosis: a systematic review and meta-analysis. Drug Alcohol Rev 2010, 29:437-445. 10.1111/j.1465-3362.2009.00153.x, 20636661.
32. Sun CA, Wu DM, Lin CC, Lu SN, You SL, Wang LY, Wu MH, Chen CJ. Incidence and cofactors of hepatitis C virus-related hepatocellular carcinoma: a prospective study of 12,008 men in Taiwan. Am J Epidemiol 2003, 157:674-682. 10.1093/aje/kwg041, 12697571.
33. Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K, Adair-Rohani H, Amann M, Anderson HR, Andrews KG, Aryee M, Atkinson C, Bacchus LJ, Bahalim AN, Balakrishnan K, Balmes J, Barker-Collo S, Baxter A, Bell ML, Blore JD, Blyth F, Bonner C, Borges G, Bourne R, Boussinesq M, Brauer M, Brooks P, Bruce NG, Brunekreef B, Bryan-Hancock C, Bucello C, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet 2012, 380:2224-2260. 10.1016/S0140-6736(12)61766-8, 23245609.
34. Tanaka H, Tsukuma H, Yamano H, Oshima A, Shibata H. Prospective study on the risk of hepatocellular carcinoma among hepatitis C virus-positive blood donors focusing on demographic factors, alanine aminotransferase level at donation and interaction with hepatitis B virus. Int J Cancer 2004, 112:1075-1080. 10.1002/ijc.20507, 15386355.
35. Mori M, Hara M, Wada I, Hara T, Yamamoto K, Honda M, Naramoto J. Prospective study of hepatitis B and C viral infections, cigarette smoking, alcohol consumption, and other factors associated with hepatocellular carcinoma risk in Japan. Am J Epidemiol 2000, 151:131-139. 10.1093/oxfordjournals.aje.a010180, 10645815.
36. D' Houtaud A, Adriaanse H, Field MG. Alcohol consumption in France: production, consumption, morbidity and mortality, prevention and education in the last three decades. Adv Alcohol Subst Abuse 1989, 8:19-44. 10.1300/J251v08n01_02.
37. Gual A, Colom J. Why has alcohol consumption declined in countries of southern Europe?. Addiction 1997, 92:S21-S31. 10.1111/j.1360-0443.1997.tb03392.x, 9167284.
38. Ramstedt M. Per capita alcohol consumption and liver cirrhosis mortality in 14 European countries. Addiction 2001, 96:S19-S33. 10.1080/09652140020021152, 11228075.
39. La Vecchia C. Alcohol in the Mediterranean diet: benefits and risks. Int J Vitam Nutr Res 2001, 71:210-213. 10.1024/0300-9831.71.3.210, 11582844.
40. Alcorn T. Mongolia's struggle with liver cancer. Lancet 2011, 377:1139-1140. 10.1016/S0140-6736(11)60448-0, 21465699.
41. Dondog B, Lise M, Dondov O, Baldandorj B, Franceschi S. Hepatitis B and C virus infections in hepatocellular carcinoma and cirrhosis in Mongolia. Eur J Cancer Prev 2011, 20:33-39. 10.1097/CEJ.0b013e32833f0c8e, 21166097.
42. Frank C, Mohamed MK, Strickland GT, Lavanchy D, Arthur RR, Magder LS, El Khoby T, Abdel-Wahab Y, Aly Ohn ES, Anwar W, Sallam I. The role of parenteral antischistosomal therapy in the spread of hepatitis C virus in Egypt. Lancet 2000, 355:887-891. 10.1016/S0140-6736(99)06527-7, 10752705.
43. Shepard CW, Finelli L, Alter MJ. Global epidemiology of hepatitis C virus infection. Lancet Infect Dis 2005, 5:558-567. 10.1016/S1473-3099(05)70216-4, 16122679.
44. Ray Kim W. Global epidemiology and burden of hepatitis C. Microbes Infect 2002, 4:1219-1225. 10.1016/S1286-4579(02)01649-0, 12467763.
45. Perz JF, Armstrong GL, Farrington LA, Hutin YJ, Bell BP. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol 2006, 45:529-538. 10.1016/j.jhep.2006.05.013, 16879891.
46. Guha I, Iredale J. Clinical and diagnostic aspects of cirrhosis. Textbook of Hepatology, from Basic Science to Clinical Practice 2007, 1219-1225. Blackwell Publishing Ltd, Oxford, 3.
47. Madhava V, Burgess C, Drucker E. Epidemiology of chronic hepatitis C virus infection in sub-Saharan Africa. Lancet Infect Dis 2002, 2:293-302. 10.1016/S1473-3099(02)00264-5, 12062995.
48. Swiatkiewicz G. Regulating unregulated markets. Addiction 1997, 92:S67-S71. 10.1111/j.1360-0443.1997.tb03398.x, 9167290.
49. Simpura J. Alcohol and European transformation. Addiction 1997, 92:S33-S41. 10.1111/j.1360-0443.1997.tb03393.x, 9167285.
50. Lehto J. Alcohol and the future health of Europe. Addiction 1997, 92:S91-S96. 10.1111/j.1360-0443.1997.tb03401.x, 9167293.
51. Ramstedt M. Population drinking and liver cirrhosis mortality: is there a link in eastern Europe?. Addiction 2007, 102:1212-1223. 10.1111/j.1360-0443.2007.01872.x, 17565562.
52. World Health Organization: The World Health Report 2004 - Changing History.2004, []., http://www.who.int/whr/2004/en/
53. Iontchev A. Central and Eastern Europe. Alcohol and Emerging Markets: Patterns, Problems, and Responses 1998, 177-201. International Center for Alcohol Policies, Washington, Grant M.
54. Popova S, Rehm J, Patra J, Zatonski W. Comparing alcohol consumption in central and eastern Europe to other European countries. Alcohol Alcohol 2007, 42:465-473. 10.1093/alcalc/agl124, 17287207.
55. Ruzibakiev R, Kato H, Ueda R, Yuldasheva N, Hegay T, Avazova D, Kurbanov F, Zalalieva M, Tuichiev L, Achundjanov B, Mizokami M. Risk factors and seroprevalence of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infection in uzbekistan. Intervirology 2001, 44:327-332. 10.1159/000050066, 11805437.
56. Kew MC. Epidemiology of chronic hepatitis B virus infection, hepatocellular carcinoma, and hepatitis B virus-induced hepatocellular carcinoma. Pathol Biol 2010, 58:273-277. 10.1016/j.patbio.2010.01.005, 20378277.
57. World Hepatitis Alliance: Viral Hepatitis: Global Policy. 2010, []., http://www.worldhepatitisalliance.org/en/viral-hepatitis-global-policy-report-2010.html
58. Basuni AA, Butterworth L, Cooksley G, Locarnini S, Carman WF. Prevalence of HBsAg mutants and impact of hepatitis B infant immunisation in four Pacific Island countries. Vaccine 2004, 22:2791-2799. 10.1016/j.vaccine.2004.01.046, 15246613.
59. Minggang C, Zheng F. Schistosomiasis control in China. Parasitol Int 1999, 48:11-19. 10.1016/S1383-5769(99)00004-5, 11269321.
60. Utzinger J, Zhou XN, Chen MG, Bergquist R. Conquering schistosomiasis in China: the long march. Acta Trop 2005, 96:69-96. 10.1016/j.actatropica.2005.08.004, 16312039.
61. Davies S. Annual Report of the Chief Medical Officer, Volume One, 2011, On the State of the Public's Health 2012, Department of Health, London.
62. Dunbar JK, Crombie IK. The rising tide of liver cirrhosis mortality in the UK: can its halt be predicted?. Alcohol Alcohol 2011, 46:459-463. 10.1093/alcalc/agr042, 21543350.
63. Global Status Report on Alcohol and Health 2012, World Health Organization Press, Switzerland.
64. Pincock S. Binge drinking on rise in UK and elsewhere. Government report shows increases in alcohol consumption, cirrhosis, and premature deaths. Lancet 2003, 362:1126-1127. 10.1016/S0140-6736(03)14502-3, 14552335.
65. Bellentani S, Saccoccio G, Costa G, Tiribelli C, Manenti F, Sodde M, Saveria Crocè L, Sasso F, Pozzato G, Cristianini G, Brandi G. Drinking habits as cofactors of risk for alcohol induced liver damage. Dionysos Study Group. Gut 1997, 41:845-850. 10.1136/gut.41.6.845, 9462221.
66. Kerr WC, Fillmore KM, Marvy P. Beverage-specific alcohol consumption and cirrhosis mortality in a group of English-speaking beer-drinking countries. Addiction 2000, 95:339-346. 10.1046/j.1360-0443.2000.9533394.x, 10795350.
67. Becker U, Grønbaek M, Johansen D, Sørensen TI. Lower risk for alcohol-induced cirrhosis in wine drinkers. Hepatology 2002, 35:868-875. 10.1053/jhep.2002.32101, 11915033.
68. McAvoy NC, Hayes PC. The cirrhosis epidemic in the UK: evaluating the causes in a European context. Expert Rev Gastroenterol Hepatol 2007, 1:41-45. 10.1586/17474124.1.1.41, 19072432.
69. Williams R. Global challenges in liver disease. Hepatology 2006, 44:521-526. 10.1002/hep.21347, 16941687.
70. Medina E, Kaempffer AM. Liver cirrhosis in Chile: epidemiologic considerations. Rev Med Chil 1993, 121:1324-1331. 8191144.
71. Torres-Poveda K, Burguete-García AI, Madrid-Marina V. Liver cirrhosis and hepatocellular carcinoma in Mexico: impact of chronic infection by hepatitis viruses B and C. Ann Hepatol 2011, 10:556-558. 21911898.
72. Méndez-Sánchez N, Aguilar-Ramírez JR, Reyes A, Dehesa M, Juórez A, Castñeda B, Sánchez-Avila F, Poo JL, Guevara González L, Lizardi J, Valdovinos MA, Uribe M, Contreras AM, Tirado P, Aguirre J, Rivera-Benítez C, Santiago-Santiago R, Bosques-Padilla F, Muñoz L, Guerroro A, Ramos M, Rodríguez-Hernández H, Jacobo-Karam J. Etiology of liver cirrhosis in Mexico. Ann Hepatol 2004, 3:30-33. 15118577.
73. Kew MC. Progress towards the comprehensive control of hepatitis B in Africa: a view from South Africa. Gut 1996, 38:S31-S36. 10.1136/gut.38.Suppl_2.S31, 8786050.
74. Wiersma ST: Hepatitis B Immunization: Where do we go from Here? 2009, : []., www.who.int/immunization/newsroom/180209_S_Wiersma.pdf
75. Tsega E, Nordenfelt E, Hansson BG, Mengesha B, Lindberg J. Chronic liver disease in Ethiopia: a clinical study with emphasis on identifying common causes. Ethiop Med J 1992, 30:1-33. 1319901.
76. Tsega E, Nordenfelt E, Hansson BG. Hepatitis C virus infection and chronic liver disease in Ethiopia where hepatitis B infection is hyperendemic. Trans R Soc Trop Med Hyg 1995, 89:171-174. 10.1016/0035-9203(95)90482-4, 7539952.
77. Frommel D, Tekle-Haimanot R, Berhe N, Aussel L, Verdier M, Preux PM, Denis F. A survey of antibodies to hepatitis C virus in Ethiopia. Am J Trop Med Hyg 1993, 49:435-439. 7692753.
78. Lozano R, Lopez AD, Atkinson C, Naghavi M, Flaxman AD, Murray CJ. Performance of physician-certified verbal autopsies: multisite validation study using clinical diagnostic gold standards. Popul Health Metr 2011, 9:32. 10.1186/1478-7954-9-32, 21816104.
79. Yang G, Rao C, Ma J, Wang L, Wan X, Dubrovsky G, Lopez AD. Validation of verbal autopsy procedures for adult deaths in China. Int J Epidemiol 2006, 35:741-748. 10.1093/ije/dyi181, 16144861.
80. Attia MA. Prevalence of hepatitis B and C in Egypt and Africa. Antivir Ther (Lond) 1998, 3:1-9.
81. Ahmad K. Pakistan: a cirrhotic state?. Lancet 2004, 364:1843-1844. 10.1016/S0140-6736(04)17458-8, 15565744.
82. El-Khoby T, Galal N, Fenwick A, Barakat R, El-Hawey A, Nooman Z, Habib M, Abdel-Wahab F, Gabr NS, Hammam HM, Hussein MH, Mikhail NN, Cline BL, Strickland GT. The epidemiology of schistosomiasis in Egypt: summary findings in nine governorates. Am J Trop Med Hyg 2000, 62:88-99. 10813505.
83. Poynard T, Naveau S, Doffoel M, Boudjema K, Vanlemmens C, Mantion G, Messner M, Launois B, Samuel D, Cherqui D, Pageaux G, Bernard PH, Calmus Y, Zarski JP, Miguet JP, Chaput JC. Evaluation of efficacy of liver transplantation in alcoholic cirrhosis using matched and simulated controls: 5-year survival. Multi-centre group. J Hepatol 1999, 30:1130-1137. 10.1016/S0168-8278(99)80269-4, 10406193.
84. United Network for Organ Sharing: National Data Reports. 2013, : []., http://www.unos.org/donation/index.php?topic=data
85. Sonderegger-Iseli K, Burger S, Muntwyler J, Salomon F. Diagnostic errors in three medical eras: a necropsy study. Lancet 2000, 355:2027-2031. 10.1016/S0140-6736(00)02349-7, 10885353.
86. Roulson J, Benbow EW, Hasleton PS. Discrepancies between clinical and autopsy diagnosis and the value of post mortem histology; a meta-analysis and review. Histopathology 2005, 47:551-559. 10.1111/j.1365-2559.2005.02243.x, 16324191.
87. Autopsy as an Outcome and Performance Measure: Summary. In Summary- AHRQ Evidence Report Summaries- NCBI Bookshelf.. (accessed December, 2012).., http://www.ncbi.nlm.nih.gov/books/NBK11951/
88. Rao C, Yang G, Hu J, Ma J, Xia W, Lopez AD. Validation of cause-of-death statistics in urban China. Int J Epidemiol 2007, 36:642-651. 10.1093/ije/dym003, 17329316.
89. Pattaraarchachai J, Rao C, Polprasert W, Porapakkham Y, Pao-In W, Singwerathum N, Lopez AD. Cause-specific mortality patterns among hospital deaths in Thailand: validating routine death certification. Popul Health Metr 2010, 8:12. 10.1186/1478-7954-8-12, 20482759.
90. Khosravi A, Rao C, Naghavi M, Taylor R, Jafari N, Lopez AD. Impact of misclassification on measures of cardiovascular disease mortality in the Islamic Republic of Iran: a cross-sectional study. Bull World Health Organ 2008, 86:688-696. 10.2471/BLT.07.046532, 18797644.
91. Gluud C. Mortality from cirrhosis: lack of progress over the last 35 years. Gut 2005, 54:1523-1526. 10.1136/gut.2005.072876, 16227356.
92. Kim YS, Um SH, Ryu HS, Lee JB, Lee JW, Park DK, Kim YS, Jin YT, Chun HJ, Lee HS, Lee SW, Choi JH, Kim CD, Hyun JH. The prognosis of liver cirrhosis in recent years in Korea. J Korean Med Sci 2003, 18:833-841. 10.3346/jkms.2003.18.6.833, 14676440.
93. Huang LM, Lu CY, Chen DS. Hepatitis B virus infection, its sequelae, and prevention by vaccination. Curr Opin Immunol 2011, 23:237-243. 10.1016/j.coi.2010.12.013, 21257300.
94. Schillie SF, Murphy TV. Seroprotection after recombinant hepatitis B vaccination among newborn infants: a review. Vaccine 2013, 31:2506-2516. 10.1016/j.vaccine.2012.12.012, 23257713.
95. Ahmad O, Boschi-Pinto C, Lopez A, Murray CJ, Lozano R, Inoue M. Age Standardization of Rates: A new WHO Standard. GPE Discussion Paper Series: No. 31 2001, World Health Organization, Geneva.